Key result
Intravenous pretreatment with magnolol significantly prevented increases in myocardial injury markers, reduced apoptosis, and improved left ventricular function following renal ischemia/reperfusion.
Why the study?
To investigate whether magnolol, a component of Magnolia officinalis bark, can reduce myocardial injury induced by renal ischemia and reperfusion.
Does magnolol reduce myocardial injury induced by renal ischemia and reperfusion in Sprague-Dawley rats?
Does magnolol reduce myocardial injury induced by renal ischemia and reperfusion in Sprague-Dawley rats?
Magnolol pretreatment reduces myocardial injury and improves left ventricular function following renal ischemia/reperfusion in a rat model.
Hypothesis-generating for magnolol in renal ischemia-reperfusion; should not change clinical practice.
BACKGROUND: Magnolol is a component of the bark of Magnolia officinalis, which is a traditional herbal remedy used in China. In this study, we investigated whether magnolol can reduce myocardial injury induced by renal ischemia and reperfusion (I/R). METHODS: Renal I/R was elicited by a 60-minute occlusion of the bilateral renal arteries and a 24-hour reperfusion in Sprague-Dawley rats. Magnolol was administered intravenously 10 minutes before renal I/R to evaluate its effects on myocardial injury induced by renal I/R. RESULTS: Renal I/R significantly increased the serum levels of creatine phosphokinase (CPK), lactate dehydrogenase (LDH), and cardiac troponin I and caused myocardial damage. The terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling-positive nuclei and caspase-3 activation was significantly increased in the myocardium, indicating increase of apoptosis. Echocardiography revealed left ventricular dysfunction, as evidenced by reduction of left ventricular ejection fraction and left ventricular fractional shortening. Furthermore, serum levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 were significantly elevated, while the IL-10 level was suppressed. However, intravenously, pretreatment with magnolol at doses of 0.003 and 0.006 mg/kg 10 minutes before renal I/R significantly prevented the increases of CPK, LDH, and cardiac troponin I levels, as well as the histological damage and the apoptosis in the myocardium. Echocardiography showed significant improvement of left ventricular function. Furthermore, the increases in TNF-α, IL-1β, and IL-6 and the decrease in IL-10 were significantly limited, while Bcl-2 was increased and Bax was decreased in the myocardium. Phosphorylation of Akt and extracellular signal-regulated kinases 1 and 2 was increased, while phosphorylation of p38 and c-Jun N-terminal kinase was reduced. CONCLUSION: Magnolol reduces myocardial injury induced by renal I/R. The underlying mechanisms for this effect might be related to modulation of the production of pro- and anti-inflammatory cytokines and the limiting of apoptosis.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2022) studied Myocardial injury induced by renal ischemia and reperfusion. Magnolol vs. Renal ischemia and reperfusion without magnolol was evaluated on Myocardial injury markers (CPK, LDH, cardiac troponin I), apoptosis, and left ventricular function. Intravenous pretreatment with magnolol significantly prevented increases in myocardial injury markers, reduced apoptosis, and improved left ventricular function following renal ischemia/reperfusion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: